| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.03 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |